Beyond neurons: Oligodendrocyte dysfunction and myelin pathophysiology in alcohol use disorder
Physiology & Behavior · 2026
DOI: 10.1016/j.physbeh.2026.115471 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physiology & Behavior, 2026. Verfasst von Hazen Westover und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology and Neuroscience, Loyola University Chicago, Maywood, IL, USA. Hauptthemen laut MEDLINE: Myelin Sheath, Oligodendroglia, Alcoholism, Neurons. Die Arbeit nennt 123 Literaturangaben. Gefördert von: National Institutes of Health.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pharmacology and Neuroscience, Loyola University Chicago, Maywood, IL, USA.
- Department of Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
- Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
- Department of Molecular Pharmacology and Neuroscience, Loyola University Chicago, Maywood, IL, USA. Electronic address: lcarvalho@luc.edu.
Förderung
- National Institutes of Health
Zitieren
APA
Westover, H., Melamed, E., Wolstenholme, J. T., & Carvalho, L. (2026). Beyond neurons: Oligodendrocyte dysfunction and myelin pathophysiology in alcohol use disorder. Physiology & Behavior. https://doi.org/10.1016/j.physbeh.2026.115471
Vancouver
Westover H, Melamed E, Wolstenholme JT, Carvalho L. Beyond neurons: Oligodendrocyte dysfunction and myelin pathophysiology in alcohol use disorder. Physiology & Behavior. 2026. doi:10.1016/j.physbeh.2026.115471
BibTeX
@article{Westover2026,
author = {Westover, Hazen and Melamed, Esther and Wolstenholme, Jennifer T and Carvalho, Luana},
title = {Beyond neurons: Oligodendrocyte dysfunction and myelin pathophysiology in alcohol use disorder},
journal = {Physiology & Behavior},
year = {2026},
doi = {10.1016/j.physbeh.2026.115471}
}
EUVIMED